Michael F. Demane - May 25, 2023 Form 4 Insider Report for NEVRO CORP (NVRO)

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael F. DeMane
Stock symbol
NVRO
Transactions as of
May 25, 2023
Transactions value $
$0
Form type
4
Date filed
5/30/2023, 05:39 PM
Previous filing
Apr 14, 2023
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +6.75K +6.69% $0.00 108K May 25, 2023 Direct F1, F2
holding NVRO Common Stock 164K May 25, 2023 See footnote F3
holding NVRO Common Stock 82.5K May 25, 2023 See footnote F4
holding NVRO Common Stock 91.2K May 25, 2023 See footnote F5
holding NVRO Common Stock 18.3K May 25, 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer.
F2 Includes 6,754 RSUs.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.